Feature:

Heart Disease

Add to Favorites Subscribe Share
fbshare-Heart Disease

Showing results

110 of 2833
Newswise: Heart and Lung Surgery Patients May Be at High Risk for Opioid Dependence
  • Embargo expired:
    22-Aug-2019 12:00 AM EDT

Article ID: 717594

Heart and Lung Surgery Patients May Be at High Risk for Opioid Dependence

The Society of Thoracic Surgeons

The amount of opioids prescribed for patients after heart and lung surgery has a direct relationship with the risk for opioid dependency and “persistent opioid use” several months after the operation.

Released:
16-Aug-2019 12:05 PM EDT

Article ID: 717656

Baylor Scott & White Health’s 15 Years of Research Brings More Access to Innovative Heart Care

Baylor Scott and White Health

On Aug. 16, the U.S. Food and Drug Administration (FDA) approved a minimally invasive open-heart surgery alternative for low surgical-risk patients following the successful outcome of the PARTNER 3 and Evolut LR clinical trials. Baylor Scott & White The Heart Hospital – Plano and Baylor Scott & White Medical Center – Temple participated in the PARTNER 3 trial and Baylor Scott & White Heart and Vascular Hospital – Dallas participated in the Evolut LR trial, following FDA approval of transcatheter aortic valve replacement (TAVR) for inoperable patients in 2012, high-risk patients in 2014 and medium-risk patients in 2017.

Released:
19-Aug-2019 1:30 PM EDT
Embargo will expire:
23-Aug-2019 12:00 AM EDT
Released to reporters:
19-Aug-2019 11:00 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 23-Aug-2019 12:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

  • Embargo expired:
    19-Aug-2019 11:00 AM EDT

Article ID: 717587

Don’t Miss a Beat: Computer Simulations May Treat Most Common Heart Rhythm Disorder

Johns Hopkins University

Scientists at Johns Hopkins have successfully created personalized digital replicas of the upper chambers of the heart and used them to guide the precise treatment of patients suffering from persistent irregular heartbeats. These simulations accurately identified where clinicians need to destroy tissue to restore the heart’s normal rhythm.

Released:
16-Aug-2019 1:45 PM EDT
Newswise: Compound could help improve heart attack recovery
  • Embargo expired:
    19-Aug-2019 5:00 AM EDT

Article ID: 717598

Compound could help improve heart attack recovery

Virginia Tech

Scientists at the Fralin Biomedical Research Institute at VTC -- a research institute of Virginia Tech -- discovered a new compound that could shield heart tissue before a heart attack, as well as preserve healthy cells when administered afterward.

Released:
16-Aug-2019 1:35 PM EDT
Newswise: Experts Caution Against Catch-all Assumptions About LVADs and Mitral Regurgitation

Article ID: 717578

Experts Caution Against Catch-all Assumptions About LVADs and Mitral Regurgitation

Michigan Medicine - University of Michigan

New research suggests LVADs may not solve mitral regurgitation for some patients with poor right heart function.

Released:
16-Aug-2019 10:05 AM EDT

Showing results

110 of 2833

Chat now!